Director Michael Auerbach resigns from atai Life Sciences board; board size reduced to 6

ATAI Life Sciences N.V.

Michael Auerbach resigned from the Supervisory Board and its compensation committee effective Jan 19, 2025.
Resignation not due to any disagreement with the company on operations, policies, or practices.
Supervisory Board size decreased from seven to six directors following his departure.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Michael Auerbach

Member of the Supervisory Board

ATAI Life Sciences N.V.

Effective: 2025-01-19
Filed: January 24, 2025, 6:59 PM ET

On January 19, 2025, Mr. Michael Auerbach resigned as a member of the supervisory board of directors (the “Supervisory Board”) of atai Life Sciences N.V. (the “Company”) and of the Supervisory Board’s compensation committee.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael Auerbach resigned as Member of the Supervisory Board at ATAI Life Sciences N.V..

Action: resigned
Role: Member of the Supervisory Board

Exact text from the filing

On January 19, 2025, Mr. Michael Auerbach resigned as a member of the supervisory board of directors (the “Supervisory Board”) of atai Life Sciences N.V. (the “Company”) and of the Supervisory Board’s compensation committee.

View on SEC.gov

Source: SEC EDGAR

accession 0001140361-25-001894

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.